Lipocine Inc.
LPCN
$3.09
-$0.16-4.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.99% | 46.90% | 40.12% | 100.05% | 75.12% |
| Total Depreciation and Amortization | 83.28% | 70.64% | 49.23% | 43.71% | 44.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.87% | -106.69% | -108.56% | -112.51% | -121.12% |
| Change in Net Operating Assets | 156.26% | -133.05% | -106.76% | -148.03% | -118.97% |
| Cash from Operations | -3.92% | -5.68% | -1.22% | 89.71% | 57.67% |
| Capital Expenditure | 88.80% | -879.35% | -879.35% | -582.58% | 11.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.10% | 18.32% | 66.52% | -80.64% | -65.52% |
| Cash from Investing | 15.15% | 16.61% | 64.35% | -81.31% | -65.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.63% | -87.79% | -48.94% | -48.94% | -48.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 485.71% | -- | 100.00% |
| Cash from Financing | 6.32% | -87.91% | -45.99% | -48.27% | -49.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.98% | -8.91% | 116.19% | -11.65% | -119.68% |